PROGNOSTIC IMPACT OF DNA CONTENT AND AUER CLASSIFICATION IN PRIMARY FALLOPIAN-TUBE CARCINOMA

被引:3
作者
ROSEN, AC
GRAF, AH
HACKER, GW
KLEIN, M
LAHOUSEN, M
VAVRA, N
REINER, A
机构
[1] SALZBURG GEN HOSP, DEPT OBSTET & GYNECOL, SALZBURG, AUSTRIA
[2] SALZBURG GEN HOSP, INST PATHOL ANAT, IMMUNOHIST & BIOCHEM UNIT, SALZBURG, AUSTRIA
[3] HANUSCHHOSP, DEPT OBSTET & GYNECOL, VIENNA, AUSTRIA
[4] GRAZ UNIV, DEPT OBSTET & GYNECOL, GRAZ, AUSTRIA
[5] UNIV VIENNA, DEPT OBSTET & GYNECOL, VIENNA, AUSTRIA
[6] UNIV VIENNA, DEPT PATHOL, VIENNA, AUSTRIA
关键词
DNA PLOIDY; FALLOPIAN TUBE CANCER; AUER CLASSIFICATION;
D O I
10.1016/0304-3835(95)03760-T
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
DNA ploidy has been studied in 61 primary fallopian tube carcinomas using image-cytometry. The investigation also included survival analysis, and ploidy classification according to AUER was performed in order to evaluate its prognostic impact for fallopian tube carcinoma. A high number of aneuploid cases were observed (79% aneuploid vs. 21% euploid tumors). The high incidence of aneuploid tumors was consistently observed among all FIGO-stages as well as all groups of histologic grading. There was no correlation between ploidy and FIGO-stage or histologic grading. Patients with euploid DNA content showed a median survival of 34 months compared to 24 months for aneuploid cases (log-rank, P = 0.83). No correlation between the AUER classification and FIGO-stage or histologic grading could be observed. Tumors with an AUER type I and II (75th quantile 41 months) showed a better outcome than tumors with AUER III and IV (75th quantile 19 months). Although these results did not reach statistical significance (P = 0.07), a trend could be observed. Therefore, AUER classification may be useful as an objective prognostic parameter. The high incidence of aneuploid tumors could be an expression of the high biologic aggressiveness of primary fallopian tube cancer which has been repeatedly mentioned in the past.
引用
收藏
页码:97 / 103
页数:7
相关论文
共 33 条
[1]  
BARNABEI VM, 1990, AM J OBSTET GYNECOL, V162, P1584
[2]   A PROSPECTIVE COMPARISON OF DNA QUANTITATION BY IMAGE AND FLOW-CYTOMETRY [J].
BAUER, TW ;
TUBBS, RR ;
EDINGER, MG ;
SUIT, PF ;
GEPHARDT, GN ;
LEVIN, HS .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 93 (03) :322-326
[3]   PLOIDY ANALYSIS OF EPITHELIAL OVARIAN CANCERS USING IMAGE CYTOMETRY [J].
BERCHUCK, A ;
BOENTE, MP ;
KERNS, BJ ;
KINNEY, RB ;
SOPER, JT ;
CLARKEPEARSON, DL ;
BAST, RC ;
BACUS, SS .
GYNECOLOGIC ONCOLOGY, 1992, 44 (01) :61-65
[4]   TUMOR DNA CONTENT AS A PROGNOSTIC FEATURE IN ADVANCED EPITHELIAL OVARIAN-CARCINOMA [J].
BLUMENFELD, D ;
BRALY, PS ;
BENEZRA, J ;
KLEVECZ, RR .
GYNECOLOGIC ONCOLOGY, 1987, 27 (03) :389-402
[5]  
BOCKING A, 1984, ANAL QUANT CYTOL, V6, P1
[6]  
BRESCIA RJ, 1990, CANCER, V65, P141, DOI 10.1002/1097-0142(19900101)65:1<141::AID-CNCR2820650128>3.0.CO
[7]  
2-I
[8]   CYTOCHEMICAL CHANGES IN THE NUCLEUS DURING TUMOR-DEVELOPMENT [J].
CASPERSSON, T ;
AUER, G ;
FALLENIUS, A ;
KUDYNOWSKI, J .
HISTOCHEMICAL JOURNAL, 1983, 15 (04) :337-362
[9]  
COX DR, 1972, J R STAT SOC B, V34, P187